Skip to main content

and
  1. Article

    Open Access

    A novel Menin-MLL1 inhibitor, DS-1594a, prevents the progression of acute leukemia with rearranged MLL1 or mutated NPM1

    Mixed lineage leukemia 1-rearranged (MLL1-r) acute leukemia patients respond poorly to currently available treatments and there is a need to develop more effective therapies directly disrupting the Menin‒MLL1 com...

    Masashi Numata, Noriyasu Haginoya, Machiko Shiroishi in Cancer Cell International (2023)

  2. Article

    Open Access

    Establishment of a transgenic mouse to model ETV7 expressing human tumors

    The ETS transcription factor ETV7 has been characterized as a hematopoietic oncoprotein, which requires cooperating mutations for its leukemogenic activity. Although the ETV7 gene is highly conserved among verteb...

    Masashi Numata, R. I. Klein Geltink, Gerard C. Grosveld in Transgenic Research (2019)